<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>NEW GENERATION ANTIBIOTICS AND THEIR EFFECTIVENESS</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Bo'riyev</mods:namePart><mods:namePart type="family">Muhammadali</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Samariddin</mods:namePart><mods:namePart type="family">Aliqulov</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Modern medicine is facing a growing problem of antibiotic resistance, which necessitates the development and implementation of new antibacterial drugs. This paper examines new-generation antibiotics, their mechanisms of action, spectrum of activity, and clinical effectiveness.
Special attention is given to innovative approaches, including combination drugs, β-lactamase inhibitors, and promising novel molecules. It is shown that new antibiotics are capable of overcoming microbial resistance and expanding the possibilities for the treatment of severe infections.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-05-30</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>SIR Publishers</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>